Clinical and Economic Outcomes With the Use of SERI® Surgical Scaffold in Direct-to-implant Breast Reconstruction

NCT02033590 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Strategic priorities impacted study

Conditions

Breast Reconstruction

Interventions

DEVICE: Biodegradable (purified) surgical silk scaffold

Sponsor

Sofregen Medical, Inc.